Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELON CORP Director's Dealing 2016

Jan 19, 2016

30044_dirs_2016-01-19_b0ddf123-6dfd-4204-9097-e5a26445f354.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2015-12-31

Reporting Person: Von Hoene William A. Jr. (Sr. Executive Vice President)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 74744 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Unit Awards $0 Common Stock (46492) 46492 Direct
Restricted Stock Unit Grant 10/21/2013 $0 Common Stock (20000) 20000 Direct
Deferred Compensation Equivalent Shares $0 Common Stock (3129) 3129 Direct
NQ Stock Option 03/12/2012 $39.81 Common Stock (88000) 88000 Direct
NQ Stock Option 01/24/2011 $43.4 Common Stock (67000) 67000 Direct
NQ Stock Option 01/25/2010 $46.09 Common Stock (33000) 33000 Direct
NQ Stock Option 01/26/2009 $56.51 Common Stock (25200) 25200 Direct
NQ Stock Option 01/28/2008 $73.29 Common Stock (19000) 19000 Direct
NQ Stock Option 01/22/2007 $59.96 Common Stock (19000) 19000 Direct
NQ Stock Option 01/23/2006 $58.55 Common Stock (17000) 17000 Direct

Footnotes

F1: Balance includes the following shares acquired through dividend reinvestment: 692, 679, 750 and 850 shares acquired on March 10, 2015, June 10, 2015, September 10, 2015 and December 10, 2015 respectively.

F2: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made.

F3: Balance consists of unvested shares remaining from the awards granted in January of the previous three years along with reinvested dividends as follows: 431, 409, 474 and 538 shares acquired on March 10, 2015, June 10, 2015, September 10, 2015 and December 10, 2015 respectively.

F4: Restricted stock grant made pursuant to the Exelon Long Term Incentive Plan. 100% of the shares will vest on October 21, 2018.

F5: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition.

F6: Balance inlcudes 27, 28, 29 and 33 share equivalents accrued on February 11, 2015, May 13, 2015, August 12, 2015 and November 11, 2015 thorugh automatic dividend reinvestment.

F7: Non qualified employee stock options, awarded pursuant to the Exelon Long Term Incentive Plan. Options vest in 1/4 increments on each of the first four anniversaries of the grant date, referenced in column one, and expire on the tenth anniversay of the grant date.